Isomorphic Labs raises $5 billion to push drug candidates toward clinical trials
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs closed a $5 billion Series C round. The money goes toward moving its drug candidates into clinical trials, continuing work on its AI drug design engine and expanding the types of drugs it targets.
Why it matters: A $5 billion round gives Isomorphic Labs room to keep building its AI drug design engine and carry candidates toward clinical trials.